These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28870916)

  • 21. Decreased expression of hMLH1 correlates with reduced 5-fluorouracil-mediated apoptosis in colon cancer cells.
    Fujita H; Kato J; Horii J; Harada K; Hiraoka S; Shiraha H; Sakaguchi K; Shiratori Y
    Oncol Rep; 2007 Nov; 18(5):1129-37. PubMed ID: 17914563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabotropic glutamate receptor 4-mediated 5-Fluorouracil resistance in a human colon cancer cell line.
    Yoo BC; Jeon E; Hong SH; Shin YK; Chang HJ; Park JG
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4176-84. PubMed ID: 15217955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-Fluorouracil efficiently enhanced apoptosis induced by adenovirus-mediated transfer of caspase-8 in DLD-1 colon cancer cells.
    Uchida H; Shinoura N; Kitayama J; Watanabe T; Nagawa H; Hamada H
    J Gene Med; 2003 Apr; 5(4):287-99. PubMed ID: 12692863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of DNA demethylase and histone methyltransferase upregulates Nrf2 in 5-fluorouracil-resistant colon cancer cells.
    Kang KA; Piao MJ; Ryu YS; Kang HK; Chang WY; Keum YS; Hyun JW
    Oncotarget; 2016 Jun; 7(26):40594-40620. PubMed ID: 27259240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.
    Li PL; Zhang X; Wang LL; Du LT; Yang YM; Li J; Wang CX
    Carcinogenesis; 2015 Dec; 36(12):1484-93. PubMed ID: 26442524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selenium Nanoparticles Induce the Chemo-Sensitivity of Fluorouracil Nanoparticles in Breast and Colon Cancer Cells.
    Abd-Rabou AA; Shalby AB; Ahmed HH
    Biol Trace Elem Res; 2019 Jan; 187(1):80-91. PubMed ID: 29748931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancing 5-fluorouracil efficacy through suppression of PKM2 in colorectal cancer cells.
    Cao Y; Lin Y; Wang D; Pan D; Zhang Y; Jin Y; Zheng C
    Cancer Chemother Pharmacol; 2018 Dec; 82(6):1081-1086. PubMed ID: 30155759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis.
    Ghosh S; Singh R; Vanwinkle ZM; Guo H; Vemula PK; Goel A; Haribabu B; Jala VR
    Theranostics; 2022; 12(12):5574-5595. PubMed ID: 35910798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Violacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cells.
    Kodach LL; Bos CL; Durán N; Peppelenbosch MP; Ferreira CV; Hardwick JC
    Carcinogenesis; 2006 Mar; 27(3):508-16. PubMed ID: 16344270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TWEAK/Fn14 signaling mediates gastric cancer cell resistance to 5-fluorouracil via NF-κB activation.
    Kwon OH; Kim JH; Kim SY; Kim YS
    Int J Oncol; 2014 Feb; 44(2):583-90. PubMed ID: 24337061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD.
    Chai J; Dong W; Xie C; Wang L; Han DL; Wang S; Guo HL; Zhang ZL
    IUBMB Life; 2015 Mar; 67(3):191-201. PubMed ID: 25873402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of RhoGDI2 in the resistance of colon cancer cells to 5-fluorouracil.
    Zheng Z; Li J; He X; Chen X; Yu B; Ji J; Zhang J; Wang T; Gu Q; Zhu Z; Liu B
    Hepatogastroenterology; 2010; 57(102-103):1106-12. PubMed ID: 21410040
    [TBL] [Abstract][Full Text] [Related]  

  • 33.  Thymosin β10 as a predictive biomarker of response to 5-fluorouracil chemotherapy in cholangiocarcinoma.
    Sribenja S; Natthasirikul N; Vaeteewoottacharn K; Sawanyawisuth K; Wongkham C; Jearanaikoon P; Wongkham S
    Ann Hepatol; 2016; 15(4):577-85. PubMed ID: 27236157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose-regulated protein 78 contributes to the proliferation and tumorigenesis of human colorectal carcinoma via AKT and ERK pathways.
    Zhou X; Xing X; Zhang S; Liu L; Wang C; Li L; Ji Q; Liu H
    Oncol Rep; 2016 Nov; 36(5):2723-2730. PubMed ID: 27634156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits.
    Denise C; Paoli P; Calvani M; Taddei ML; Giannoni E; Kopetz S; Kazmi SM; Pia MM; Pettazzoni P; Sacco E; Caselli A; Vanoni M; Landriscina M; Cirri P; Chiarugi P
    Oncotarget; 2015 Dec; 6(39):41706-21. PubMed ID: 26527315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. l-carnosine dipeptide overcomes acquired resistance to 5-fluorouracil in HT29 human colon cancer cells via downregulation of HIF1-alpha and induction of apoptosis.
    Iovine B; Guardia F; Irace C; Bevilacqua MA
    Biochimie; 2016 Aug; 127():196-204. PubMed ID: 27234614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melatonin synergizes the chemotherapeutic effect of 5-fluorouracil in colon cancer by suppressing PI3K/AKT and NF-κB/iNOS signaling pathways.
    Gao Y; Xiao X; Zhang C; Yu W; Guo W; Zhang Z; Li Z; Feng X; Hao J; Zhang K; Xiao B; Chen M; Huang W; Xiong S; Wu X; Deng W
    J Pineal Res; 2017 Mar; 62(2):. PubMed ID: 27865009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of the p38 MAPK pathway sensitises human colon cancer cells to 5-fluorouracil treatment.
    Yang SY; Miah A; Sales KM; Fuller B; Seifalian AM; Winslet M
    Int J Oncol; 2011 Jun; 38(6):1695-702. PubMed ID: 21424124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of GSK3B bypass drug resistance of p53-null colon carcinomas by enabling necroptosis in response to chemotherapy.
    Grassilli E; Narloch R; Federzoni E; Ianzano L; Pisano F; Giovannoni R; Romano G; Masiero L; Leone BE; Bonin S; Donada M; Stanta G; Helin K; Lavitrano M
    Clin Cancer Res; 2013 Jul; 19(14):3820-31. PubMed ID: 23729362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DUOX2-mediated production of reactive oxygen species induces epithelial mesenchymal transition in 5-fluorouracil resistant human colon cancer cells.
    Kang KA; Ryu YS; Piao MJ; Shilnikova K; Kang HK; Yi JM; Boulanger M; Paolillo R; Bossis G; Yoon SY; Kim SB; Hyun JW
    Redox Biol; 2018 Jul; 17():224-235. PubMed ID: 29715584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.